Tobacco Lobby Goes Global

Multinational tobacco companies for years have been battered by politicians and lawyers in the United States and other developed nations like Australia and France. The global reputation of tobacco executives ranks near the bottom in public standing surveys. Market growth in the developed world has flattened out or declined. In the United States, the number of men who smoke dropped from 52 percent in 1965 to half that today. It appears to be so bad for the industry that one consulting group said selling tobacco represents “the worst operating environment in the world.”

No wonder. The industry’s product is the world’s single-largest preventable cause of death. Between 2005 and 2030, tobacco-related illnesses will claim as many as 176 million lives worldwide, according to the World Health Organization

And, since 2003, at least 171 countries, with some 90 percent of the world’s population, have signed onto the WHO’s Framework Convention on Tobacco Control – a legally binding international standard that governments can use to limit tobacco marketing and tamp down consumption with stern health warnings and higher cigarette With all this pressure, it’s easy to believe that Big Tobacco is down and out.

But in five decades of fighting public health advocates over the dangers of smoking, the industry has proven time and again to be an effective brawler when its revenues are threatened. In fact, Big Tobacco may well have an answer to its woes: emerging markets and developing countries.

This week in Punta del Este, Uruguay, the WHO hosts the latest round of talks on global tobacco controls, meetings expected to draw hundreds of anti-tobacco activists, public health specialists, and industry executives from around the world. Held in Geneva the past two years, it is fitting that the current summit takes place in a developing country – one now in the middle of a contentious fight with the tobacco industry over proposed smoking controls.

Over the past decade, multinational tobacco firms have increasingly aimed their formidable lobbying prowess at weak governments in fast-growing nations. Their goals seem clear enough to public health experts: derail no-smoking laws and advertising prohibitions in countries rich with potential new smokers, especially among women and youths. For the industry, this is a chance to sustain and even add to its revenues, which, despite growing tobacco controls, reached an extraordinary $300 billion for the top five companies in 2008 – larger than the gross domestic product of all but 40 countries.

An Upward Curve

While smart business for Big Tobacco, it may well be a public health disaster for nations targeted by the industry. Of the 176 million tobacco deaths predicted to occur between 2005 and 2030, 77 percent will be in developing countries. The annual cost to the global economy – in direct and indirect health care and related costs – were estimated at $500 billion last year by the World Lung Foundation, a cost that will be borne increasingly in emerging markets. Much of the industry growth is in China, by far the world’s largest tobacco market, as well as places like Russia, Indonesia, and India – nations where cigarettes are at least $3 cheaper per pack than in the United States or Western Europe.

“This was our experience,” said Gro Harlem Brundtland, former WHO director general who led the international body in the years before its tobacco controls were established. “The industry is just too strong and there is too much money at stake for them not to try to subvert the control process.”

Tobacco companies insist, however, that they abide by rules of countries in which they operate, and they appear bullish about the future. In a 2009 report, Japan Tobacco International, the third most-active global tobacco trader, stated its commitment to maintaining an annual growth rate of 10 percent, citing sales successes in places like Russia, Ukraine, Turkey, and Malaysia. British American Tobacco (BAT) boasted in its 2009 annual report that “some two-thirds of our revenue comes from developing markets.”

The growth in emerging markets is helping keep global rates of smoking on an upward curve. Despite Big Tobacco’s reputation and challenges by governments and public health advocates, an estimated 70 million people around the world started smoking between 1998 and 2008. This year the industry expects to sell more than six trillion cigarettes and cigars worldwide, up from 5.7 trillion in 2007.

Even in the United States, where statistics show 21 percent of adults are regular smokers, there is now a stall in the generation-long decline in tobacco consumers. Officials at the U.S. Centers for Disease Control and Prevention say this leveling out is due, at least in part, to tobacco industry marketing tactics.

“The industry has gotten even better at sidestepping laws designed to get people to stop smoking,” CDC director Thomas R. Frieden told reporters this year.

In a written statement, BAT defended its lobbying as above board and aimed at educating governments. “We believe the tobacco industry should be permitted to engage with regulators and participate in the development of policy that affects its business environment,” the statement says. “We always say who we are and where we’re from and we openly and transparently engage with governments to warn them of the negative impact some of these ill-thought out guidelines could have.”

Tobacco’s global rebound did not happen overnight.Russian cigarettes

For most of this year, journalists in six countries have documented the industry’s moves into emerging markets around the world. This inquiry, sponsored by the Washington, D.C.-based International Consortium of Investigative Journalists, has uncovered a long list of aggressive industry lobbying tactics from Moscow to Mexico City. Among the items in the industry’s tool kit: political campaign contributions; gifts and donations; helping regulators write new tobacco rules; threatening legal action against reforms; and in at least two cases, paying bribes to secure favorable trade deals and legislation.

It is difficult to gauge how much the industry has spent lobbying capitals in emerging markets, as the industry makes little of its political work public. ICIJ has traced millions of dollars to lobbyist firms, foundations, social clubs, and even government health ministries. Companies have donated computers to schools on behalf of politicians and made grants to favorite causes of politicians’ wives. The payoff for all this is delaying anti-smoking efforts in some countries, and derailing them entirely elsewhere.

Following the Money

As the industry spends less in the United States to lobby legislators – the amount plunged from $65 million in 1998 to $24.6 million in 2009, according to the Center for Responsive Politics – WHO officials say they are seeing more government-relations work in emerging markets. But it is difficult to quantify exactly how much is spent in developing nations. Philip Morris International and British American Tobacco do not report lobbying expenditures abroad as they do in the United States. Japan Tobacco International said it does not discuss international lobbying expenses.

Yet ICIJ found that Japan Tobacco has spent considerable sums to fight for markets in emerging markets. In India, for example, the company paid Deepak Talwar, one of the country’s top lobbyists, at least $1 million for an unsuccessful four-year campaign to ease restrictions against foreign investment in Indian tobacco manufacturing, according to industry sources. With its fast-growing economy and population, India is one of the world’s biggest tobacco markets; more than half the men, from 15 to 49 years old, smoke. Ironically, Japan Tobacco rolled into homegrown opposition from India’s powerful makers of bidis, small cigarettes, hand-rolled in tendu tree leaves, which are the choice of 100 million smokers. About 300 bidi barons control a business that produces at least 550 billion smokes per year and operate with little government oversight. Bidi tycoons are closely tied to federal politicians. More recently, Talwar has become an ally of Praful Patel, the country’s aviation minister and a leading bidi merchant.

Another industry target is Indonesia, the largest country that has yet to adopt the WHO tobacco standards. Standard cigarettes sell for about $1 a pack in Indonesia, and the domestic favorites – clove-flavored kreteks – are widely marketed to teens and children. It’s also a nation rife with official corruption – federal police are investigating several cases of alleged bribery among legislators, including some who have played roles in setting tobacco rules.

And in populous Nigeria, where per-capita consumption is just 103 cigarettes a year, ICIJ has found aggressive sales pitches to young people, especially women, via “underground” parties where free smokes are handed out, and retailers operating with scant oversight from a government addled by corruption. Last year, the Nigerian senate dropped action on a national anti-tobacco bill, after holding only one public meeting, in which tobacco makers and growers warned that the bill would wreak economic havoc in the country. Anti-tobacco activists in Nigeria say the move came as industry representatives have focused new lobbying on influential politicians and government health officials.

Still another tactic surfaced in Colombia. Last year, Philip Morris promised a $200 million investment in Colombia – just as politicians were discussing new rules designed to crack down on the industry. The agreement states that Philip Morris will contribute to tobacco seed improvement programs in the country, open a tobacco research lab, and fund forums on job creation and investment. The agreement also says it will provide “matching funds for crop substitution programs, including those that foster the growing of tobacco.”

“The timing of this agreement shows it was no mere business decision,” said Gigi Kellett, who directs tobacco research for Corporate Accountability International, a Boston-based nonprofit. The deal also conflicted with Colombia’s April 2008 adoption of the WHO agreement, which calls for producing countries to explore crop alternatives to tobacco.

As they did in Mexico, tobacco companies and their allies have raised threats of legal action against governments to blunt the impact of tough new controls.

Uruguay, for example, may end up in international court after Philip Morris warned the country to back away from plans for one of the world’s toughest anti-tobacco laws that would require dire health warnings covering 80 percent of cigarette packaging, and limit tobacco companies to selling just one variation of each brand.

Philip Morris said the country’s proposed tobacco controls violated international trade rules and would hinder its right to sell a legal product. It filed a claim with the trade-dispute settlement branch of the World Bank. Uruguay’s new president José Mujica, unwilling to take on the corporate giant, initially backed down. On July 23, the country’s health minister delivered a routine message on state television, outlining changes that would shrink the size of the health warnings and allow tobacco companies to once again sell more than one variety of each brand.

ICIJ’s examination of the Uruguay episode found that it was more than a simple claim of over-regulation by Philip Morris that led Mujica to retreat. Government sources in Uruguay say that while Philip Morris was applying legal pressure from abroad, the country’s domestic tobacco executives were privately pushing Mujica to strike a deal. The reason: Uruguayan manufacturers had complained that foreign tobacco was being sold at cut-rate prices that undermined domestic sales, and pushed for a compromise on tobacco controls as leverage to get foreign cigarette makers to raise their prices.

Since then, though, Mujica has had a change of heart. Backed by pledges of legal support from international anti-tobacco groups, the Uruguayan president now says his government may go ahead with some reforms.

Some tobacco companies simply didn’t have time for such niceties as hard-boiled lobbying and legal threats. In at least two instances, industry representatives have descended into blatant payoffs to foreign officials, earning scrutiny from federal corruption prosecutors in the United States.

Alliance One International and Universal Corp. are two U.S. suppliers of raw tobacco. In Thailand, Bobby Elkin was an executive with a company that later became Alliance. Prosecutors say Elkin orchestrated more than $500,000 in payoffs to officials from the government’s Thailand Tobacco Monopoly, which controls the nation’s cigarette industry. And in Greece, China, Kyrgyzstan, Malawi, and Mozambique, Alliance and Universal executives also doled out cash and gifts to government officials and friendly politicians.

The companies settled the cases with federal prosecutors, paying almost $30 million in combined fines. In late October, a judge in Virginia sentenced Elkin to probation, saying the former tobacco executive had faced a tough choice: conduct business how it’s done in those countries or lose a market. The judge also characterized Elkin’s actions as similar to how the CIA gathers intelligence.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Anti-spam image